Patents by Inventor Tracy Parrott

Tracy Parrott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHIC FORM OF TG02 FOR TREATING CANCER
    Publication number: 20240254141
    Abstract: The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with crystalline polymorphic forms of TG02 free base and TG02 acid addition salts.
    Type: Application
    Filed: December 6, 2023
    Publication date: August 1, 2024
    Inventors: Robert K. MANSFIELD, Tracy PARROTT
  • POLYMORPHIC FORM OF TG02 FOR TREATING CANCER
    Publication number: 20240254142
    Abstract: The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with crystalline polymorphic forms of TG02 free base and TG02 acid addition salts.
    Type: Application
    Filed: December 6, 2023
    Publication date: August 1, 2024
    Inventors: Robert K. MANSFIELD, Tracy PARROTT
  • Polymorphic form of TG02 for treating cancer
    Patent number: 12043630
    Abstract: The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with crystalline polymorphic forms of TG02 free base and TG02 acid addition salts.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: July 23, 2024
    Assignee: Cothera Bioscience, Inc.
    Inventors: Robert K. Mansfield, Tracy Parrott
  • Treatment of Cancer with TG02
    Publication number: 20200323862
    Abstract: The present disclosure provides therapeutic methods of treating a cancer patient with TG02 and a second therapeutic agent, e.g., TG02 and an immune checkpoint inhibitor, TG02 and a COX-2 inhibitor, or TG02 and an immune checkpoint inhibitor and a COX-2 inhibitor.
    Type: Application
    Filed: March 24, 2017
    Publication date: October 15, 2020
    Inventors: Thomas M. ESTOK, Eckard WEBER, Tracy PARROTT
  • Polymorphic form of TG02
    Patent number: 10544162
    Abstract: The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with crystalline polymorphic forms of TG02 free base and TG02 acid addition salts.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: January 28, 2020
    Assignee: ADASTRA PHARMACEUTICALS, INC.
    Inventors: Robert K. Mansfield, Tracy Parrott
  • Polymorphic form of TG02
    Publication number: 20190055263
    Abstract: The present disclosure provides crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, pharmaceutical compositions comprising crystalline polymorphic forms of TG02 free base and TG02 acid addition salts, and methods of treating cancer and other diseases in a patient with crystalline polymorphic forms of TG02 free base and TG02 acid addition salts.
    Type: Application
    Filed: August 17, 2018
    Publication date: February 21, 2019
    Inventors: Robert K. Mansfield, Tracy Parrott